Spruce Biosciences, Inc. (SPRB) has 18 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Novo Holdings A/S mit 2,550,000 Aktien. Weitere bedeutende Anteilseigner sind Charlton Ralph William III und Barretto-Ko Percival.
In den letzten 12 Monaten haben Insider 30 Transaktionen in SPRB Aktien getätigt — 11 Käufe (im Wert von $519.94K) und 1 Verkäufe (im Wert von $436.39). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
SPRB Insider-Beteiligungen
Größter Aktionär
Novo Holdings A/S
2,550,000 Aktien
Käufe (12 Monate)
11
$519.94K Wert
Verkäufe (12 Monate)
1
$436.39 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Novo Holdings A/s |
10 Percent Owner |
2,550,000 |
2024-03-25 |
|
| 2 |
Charlton Ralph William Iii |
Chief Medical Officer |
106,400 |
2024-12-20 |
|
| 3 |
Barretto-ko Percival |
Director |
30,000 |
2025-07-24 |
|
| 4 |
Muralidhar Bali |
Director |
30,000 |
2025-07-24 |
|
| 5 |
Ways Kirk |
Interim Chief Medical Officer |
30,000 |
2025-07-24 |
|
| 6 |
Grey Michael G |
Executive Chairman |
30,000 |
2025-07-24 |
|
| 7 |
Spiegelman Daniel K |
Director |
30,000 |
2025-07-24 |
|
| 8 |
O'donnell Niall |
Director |
30,000 |
2023-05-26 |
|
| 9 |
Aynechi Tiba |
Director |
30,000 |
2025-07-24 |
|
| 10 |
Simpson Camilla V |
Director |
30,000 |
2025-07-24 |
|
| 11 |
Chaya Moghrabi Dina |
Director |
22,500 |
2022-05-27 |
|
| 12 |
Dias Subaweerage |
Chief Medical Officer |
20,000 |
2021-12-20 |
|
| 13 |
Szwarcberg Javier B. |
Chief Executive Officer |
19,004 |
2026-01-05 |
|
| 14 |
Hooks Corwin Dale |
Chief Commercial Officer |
11,000 |
2026-03-09 |
|
| 15 |
Walbert Keli |
Director |
3,400 |
2025-12-15 |
|
| 16 |
King Richard |
Chief Executive Officer |
2,230 |
2021-07-06 |
|
| 17 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
1,051 |
2025-10-08 |
|
| 18 |
Gharib Samir M. |
President and CFO |
497 |
2025-12-17 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-09 |
Hooks Corwin Dale |
Chief Commercial Officer |
RSU-Zuteilung |
11,000 |
- |
- |
| 2026-03-09 |
Hooks Corwin Dale |
Officer |
Unbekannt |
- |
- |
- |
| 2025-12-11 |
Ways Douglas Kirk |
Interim Chief Medical Officer |
Aktienrückgabe |
400 |
$169.50 |
$67.8K |
| 2025-12-31 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU-Zuteilung |
4,690 |
$4.53 |
$21.25K |
| 2025-12-15 |
Szwarcberg Javier B. |
Chief Executive Officer |
Optionsausübung (Verkauf) |
1,480 |
- |
- |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU-Zuteilung |
1,666 |
$104.13 |
$173.48K |
| 2025-12-15 |
Gharib Samir M. |
President and CFO |
Optionsausübung (Verkauf) |
496 |
- |
- |
| 2025-12-11 |
Walbert Keli |
Director |
RSU-Zuteilung |
3,400 |
$88.41 |
$300.59K |
| 2025-12-11 |
Walbert Keli |
Officer |
Unbekannt |
- |
- |
- |
| 2025-12-11 |
Barretto-ko Percival |
Director |
Aktienrückgabe |
800 |
$169.50 |
$135.6K |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Aktienrückgabe |
10,000 |
$344.25 |
$3.44M |
| 2025-12-11 |
Simpson Camilla V |
Director |
Aktienrückgabe |
173 |
$108.00 |
$18.68K |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Aktienrückgabe |
733 |
$1,506.00 |
$1.1M |
| 2025-12-11 |
Grey Michael G |
Executive Chairman |
Aktienrückgabe |
387 |
$108.00 |
$41.8K |
| 2025-12-11 |
Spiegelman Daniel K |
Director |
Aktienrückgabe |
458 |
$564.00 |
$258.31K |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU-Steuereinbehalt |
2,194 |
$88.41 |
$193.97K |
| 2025-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Optionsausübung (Verkauf) |
1,196 |
- |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Optionsausübung (Verkauf) |
1,900 |
- |
- |
| 2025-12-10 |
Gharib Samir M. |
President and CFO |
Optionsausübung (Verkauf) |
514 |
- |
- |
| 2025-10-20 |
Szwarcberg Javier B. |
Chief Executive Officer |
Optionsausübung (Verkauf) |
4,784 |
- |
- |
| 2025-10-20 |
Gharib Samir M. |
President and CFO |
Optionsausübung (Verkauf) |
2,053 |
- |
- |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Informierter Verkauf |
25 |
$17.46 |
$436.39 |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
| 2025-07-22 |
Barretto-ko Percival |
Director |
RSU-Zuteilung |
30,000 |
$0.12 |
$3.49K |
| 2025-07-23 |
Ways Kirk |
Interim Chief Medical Officer |
RSU-Zuteilung |
30,000 |
$0.12 |
$3.71K |
